Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

21 May 2009

Parathyroid hormone in living kidney donors after nephrectomy

M Bieniasz, A Kwiatkowski, P Domagała, J Gozdowska, R Kieszek, A Darocha, J Trzebicki, M Durlik, L Pączek, A Chmura

Ann Transplant 2009; 14(1): 57-57 :: ID: 880408

Abstract

Background: Living kidney donors loose half of their renal mass in a single
surgical event. After this loss, a series of compensations take place. Thus,
living kidney donors offer a unique opportunity to study the metabolic and
functional consequences resulting from loss of renal mass. The aim of this
study was to assess parathyroid hormone (PTH) in living kidney donors after unilateral nephrectomy.
Material/Methods: Between 1995 and 2005, 66 living donor open nephrectomies were performed. Physical examination, blood and urine tests and ultrasonography were performed prior to nephrectomy and at every 12 months post operation. We assessed basal PTH level. Donor mean age was 40.9 years (range 29-60). The donors were predominantly female (52.5%). 27 donors did not report for follow-up visits. Observation period ranged from 36 to 156 months post nephrectomy.
Results: Mean creatinine concentration increased from 0.89 mg/dl presurgery to 1.12 mg/dl at 36 months and to 1.1 mg/dl at 84 months post donation. Mean creatinine clearance according to Cockroft-Gault formula decreased from 94.27 ml/min before donation to 80.2 ml/min at 36 months and to 72.2 ml/min at 84 months after donating the kidney. One patient (2.6%) had a PTH level elevated to 94 pg/ml at 78 months post operation. His creatinine clearance according to Cockroft-Gault formula was 102 ml/min. We also observed a lowered PTH level in one patient at 52 months after nephrectomy.
Conclusions: Living kidney donation does not result in serious changes in
PTH levels in our investigated group. Further study with a longer observation period may be needed to evaluate parathyroid hormone imbalance in the long-term.

Keywords: Kidney Transplantation, Living Donors

Add Comment 0 Comments

In Press

Original article  

Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...

Ann Transplant In Press; DOI: 10.12659/AOT.951568  

Original article  

Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver Transplantation

Ann Transplant In Press; DOI: 10.12659/AOT.950589  

Database Analysis  

Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...

Ann Transplant In Press; DOI: 10.12659/AOT.950289  

Original article  

Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...

Ann Transplant In Press; DOI: 10.12659/AOT.950997  

Most Viewed Current Articles

24 Aug 2021 : Review article   18,372

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

05 Apr 2022 : Original article   14,731

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

22 Nov 2022 : Original article   14,244

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

29 Dec 2021 : Original article   13,752

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358